Pediatrix Medical Group, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -4.6% | -2.3% | -8.0% | +4.1% | +3.7% | -7.4% | +5.4% | +4.6% | +2.2% | -7.9% | +2.9% | |
| – | +15.0% | -11.8% | +0.6% | +23.1% | +21.1% | -23.1% | +24.7% | +17.0% | +6.5% | -23.1% | +12.5% | |
| – | +245.9% | -89.1% | +142.6% | +435.2% | +121.5% | -57.0% | +127.1% | +51.3% | +10.3% | -45.2% | +40.4% | |
| – | +42.5% | -35.0% | +15.4% | +65.5% | +58.1% | -37.1% | +58.9% | +33.0% | +7.9% | -34.2% | +22.9% | |
| – | +0.9% | +3.2% | -5.1% | +5.1% | -5.4% | -7.3% | -2.4% | -4.7% | +3.1% | -2.2% | +0.9% | |
| – | +27.8% | -100.0% | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | -20.4% | -0.4% | -0.6% | -4.2% | -1.1% | – | – | |
| – | -9.7% | +0.7% | -11.1% | +0.0% | +0.3% | +0.0% | +0.0% | +1.0% | +0.4% | +0.6% | +0.0% | |
| – | +37.2% | -11.7% | -45.7% | +29.3% | -12.0% | -10.4% | -10.5% | +59.2% | +13.9% | -5.5% | -8.9% | |
| – | +0.9% | -4.3% | -1.8% | +4.3% | +3.2% | -13.2% | +5.3% | +3.2% | +5.5% | -13.7% | +4.8% | |
| – | +11.0% | -36.4% | +25.4% | +20.3% | +16.4% | -37.6% | +25.8% | +15.1% | +16.9% | -3.5% | +13.3% | |
| – | -2.1% | +4.0% | -2.5% | -0.6% | -8.3% | +3.2% | +4.2% | +5.1% | +2.2% | +432.1% | -2.9% | |
| – | +9.1% | -8.5% | +1.2% | +48.0% | -2.0% | -5.0% | -4.7% | -8.1% | -3.7% | -15.3% | +857.1% | |
| – | -1.6% | +13.4% | -11.6% | -0.8% | -2.3% | -0.5% | -1.1% | -1.1% | -1.1% | -30.2% | -0.1% | |
| – | -12.3% | +0.8% | -17.5% | +3.7% | +4.4% | +3.2% | +5.6% | +6.8% | -2.8% | +1.5% | +0.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +1.3% | -0.9% | +0.1% | +1.4% | +1.6% | -0.1% | +1.2% | -1.4% | -1.4% | -1.6% | -2.0% |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.